Medinotec Inc.
corporate_fare Company Profile
Medinotec Inc. (OTC:MDNC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for MDNC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-09, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for MDNC spans 10-K, 10-Q.
Recent high-impact activity:
- Medinotec Q1 Revenue Jumps 24% to $2.65M, U.S. Sales Surge 87%
- Medinotec Reports Sharp Profit Decline Despite Revenue Growth, Citing Soaring Operating Expenses
- Medinotec Reports Strong YTD Revenue Growth and Significant Debt Reduction Amidst New US Tariff and Control Weakness
Financial Snapshot
Fiscal year ended February 28, 2026
Revenue
$9.73M
Net Income
$794.5K
Op. Cash Flow
$906.8K
Free Cash Flow
$905.43K
Gross Profit
$5.13M
Operating Income
$1.09M
Cash & Equivalents
$2.76M
Debt / Equity
0.00×
Net Margin
8.2%
Shares Outstanding
11.76M sh
Source: 10-K · filed 2026-05-28 · accession 0001663577-26-000175
show_chartPrice Chart
Loading chart...